Latelines for Feb. 17, 2003
FDA Approves Pfizer’s Gene Therapy for Hemophilia B
Fidanacogene elaparvovec-dzkt (Beqvez) is a 1 time treatment that allows patients with hemophilia B to produce factor IX themselves.
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
The Stages of Shingles
The clinical manifestations of shingles can be divided into 3 phases.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Optimizing Bispecific Antibodies in Multiple Myeloma for Efficacy, Safety
A Q&A with Kirollos Hanna, PharmD, director of pharmacy at Minnesota Oncology, on the current and future landscape of bispecific antibodies in myeloma treatment.
FDA Approves Generic OTC Naloxone Nasal Spray
Amneal Pharmaceuticals said its generic naloxone hydrochloride nasal spray is now available in the US following FDA approval.
